《大行報告》富瑞上調東亞(00023.HK)目標價至15.6元 評級「買入」
東亞銀行(00023.HK)擬於場外悉數回購基金股東Elliott持有的2.46億股股份,佔總股本約8.43%。富瑞發表報告,認爲回購佔出售東亞人壽回報給股東收益的80%,雖然對中國房地產風險敞口的擔憂依然存在,但相信投資者會歡迎東亞銀行在提高股東回報方面取得的進展。該行將東亞銀行目標價由15元上調至15.6元,維持「買入」評級。
富瑞表示,回購規模超過該行早前的看漲預期,29億元的回購代價,相當於每股0.99元,而富瑞早前預期東亞出售東亞人壽後,會派特別息0.57元。該行預計,東亞回購對股價有正面作用,並預計東亞銀行可能會繼續出售非核心資產,例如藍十字保險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.